scholarly journals Circular RNA expression profile and its potential regulative role in human abdominal aortic aneurysm

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Min Zhou ◽  
Zhenyu Shi ◽  
Liang Cai ◽  
Xu Li ◽  
Yong Ding ◽  
...  
2020 ◽  
Vol 38 (7) ◽  
pp. 830-838 ◽  
Author(s):  
Rui Yang ◽  
Zhiwei Wang ◽  
Guangran Meng ◽  
Li Hua

2006 ◽  
Vol 1085 (1) ◽  
pp. 311-314 ◽  
Author(s):  
E. CHOKE ◽  
M. M THOMPSON ◽  
A. JONES ◽  
E. TORSNEY ◽  
J. DAWSON ◽  
...  

Angiology ◽  
2019 ◽  
Vol 70 (9) ◽  
pp. 830-837 ◽  
Author(s):  
Li Yuwen ◽  
Yang Ciqiu ◽  
Shi Yi ◽  
Liu Ruilei ◽  
Lai Yuanhui ◽  
...  

Cytokines play an important role in the pathogenesis of abdominal aortic aneurysm (AAA). We evaluated the cytokine expression profile of large AAA walls using a 274-cytokine protein array. We hypothesized that AAAs are characterized by an inflammatory, chemotactic cytokine profile. We investigated the cytokine expression profile of 12 patients with AAA and 6 nonaneurysmal controls using an antibody-based protein array. The array generated antibodies against homogenized human aortic tissues to validate the cytokines differentially expressed in AAAs and normal aortas. Data were quantified using fluorescent signal intensities and statistically analyzed by the t test. Fifty-nine cytokines were differentially expressed between the AAA and control samples. Of the 35 selected cytokines that had relative expression >1000, 29 were significantly higher and 6 were lower in AAA samples than in controls. They respectively belonged to CC chemokines, CXC chemokines, pro-inflammatory cytokines, growth factors, proteolytic proteins and inhibitors, and cell adhesion cytokines. Our results show that distinct cytokines are involved in AAAs and suggest that the pathways involving these cytokines may be associated with the pathogenesis and development of AAAs. These findings, if confirmed by larger studies, may suggest treatment targets.


Biochimie ◽  
2019 ◽  
Vol 162 ◽  
pp. 1-7 ◽  
Author(s):  
Fabien Lareyre ◽  
Marc Clément ◽  
Claudine Moratal ◽  
Xavier Loyer ◽  
Elixène Jean-Baptiste ◽  
...  

2015 ◽  
Vol 12 (6) ◽  
pp. 7891-7898 ◽  
Author(s):  
XUDONG CHEN ◽  
CHENGFEI ZHENG ◽  
YUNJUN HE ◽  
LU TIAN ◽  
JIANHUI LI ◽  
...  

VASA ◽  
2005 ◽  
Vol 34 (4) ◽  
pp. 217-223 ◽  
Author(s):  
Diehm ◽  
Schmidli ◽  
Dai-Do ◽  
Baumgartner

Abdominal aortic aneurysm (AAA) is a potentially fatal condition with risk of rupture increasing as maximum AAA diameter increases. It is agreed upon that open surgical or endovascular treatment is indicated if maximum AAA diameter exceeds 5 to 5.5cm. Continuing aneurysmal degeneration of aortoiliac arteries accounts for significant morbidity, especially in patients undergoing endovascular AAA repair. Purpose of this review is to give an overview of the current evidence of medical treatment of AAA and describe prospects of potential pharmacological approaches towards prevention of aneurysmal degeneration of small AAAs and to highlight possible adjunctive medical treatment approaches after open surgical or endovascular AAA therapy.


Sign in / Sign up

Export Citation Format

Share Document